MedTrace Logo

Ultrasound Based Transperineal Robotic Biopsy of the the Prostate

NCT01102361 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 250

Last updated 2010-04-13

No results posted yet for this study

Summary

The objective of the study is to examine the effectiveness and accuracy of the BioXbot in prostate biopsy as opposed to transrectal biopsy. This evaluation of the efficacy of both the procedures is based on:

* Uptake rate
* Peripheral zone reachability
* Needling accuracy
* Procedure execution time
* Post operative discomfort or trauma experienced by patient
* Quality and type of tissue sample extracted
* Adverse and unanticipated side-effects on patient after the procedure and recording any unexpected reactions

Conditions

  • Previous Negative Biopsy

Interventions

PROCEDURE

Robotic Transperineal Biopsy

Saturation biopsy for previous negative patients

Sponsors & Collaborators

  • Singapore General Hospital

    lead OTHER

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-05-31
Primary Completion
2011-01-31
Completion
2011-06-30

Countries

  • Singapore

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01102361 on ClinicalTrials.gov